Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2

Stem Cell Res. 2017 Apr:20:80-83. doi: 10.1016/j.scr.2017.02.012. Epub 2017 Mar 7.

Abstract

The thalassemias are a group of genetic disorders characterized by a deficiency in the synthesis of globin chains. In this study the MUi009-A human induced pluripotent stem cell line was successfully generated from peripheral blood CD34+ haematopoietic progenitors of a 32year old male who had coinherited a homozygous β°-thalassemia mutation at codon 41/42 (-TCTT) and a heterozygous α-thalassemia 4.2 deletion. The MUi009-A cell line exhibited embryonic stem cell characteristics with consistent pluripotency marker expression and the capability of differentiating into the three germ layers. The cell line may provide a tool for drug testing and gene therapy studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Cell Differentiation
  • Cell Line
  • Cellular Reprogramming*
  • DNA Mutational Analysis
  • Embryoid Bodies / metabolism
  • Embryoid Bodies / pathology
  • Gene Deletion
  • Genotype
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Karyotype
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Microscopy, Fluorescence
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • alpha-Thalassemia / genetics
  • alpha-Thalassemia / metabolism
  • alpha-Thalassemia / pathology*

Substances

  • Transcription Factors